Literature DB >> 29726373

Patient-reported outcomes: an essential component of oncology drug development and regulatory review.

Ethan Basch1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29726373     DOI： 10.1016/S1470-2045(18)30141-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  11 in total

1.  Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials.

Authors:  Thomas M Atkinson; Amylou C Dueck; Daniel V Satele; Gita Thanarajasingam; Jacqueline M Lafky; Jeff A Sloan; Ethan Basch
Journal:  JAMA Oncol       Date:  2020-03-01       Impact factor: 31.777

2.  Prospective development of a patient-reported outcomes instrument for desmoid tumors or aggressive fibromatosis.

Authors:  Mrinal M Gounder; LeAnne Maddux; Jean Paty; Thomas M Atkinson
Journal:  Cancer       Date:  2019-11-06       Impact factor: 6.860

3.  How are patient-reported outcomes and symptoms being measured in adults with relapsed/refractory multiple myeloma? A systematic review.

Authors:  Matthew R LeBlanc; Rachel Hirschey; Ashley Leak Bryant; Thomas W LeBlanc; Sophia K Smith
Journal:  Qual Life Res       Date:  2019-12-17       Impact factor: 4.147

4.  Profiling patient-reported symptom recovery from oesophagectomy for patients with oesophageal squamous cell carcinoma: a real-world longitudinal study.

Authors:  Xi Luo; Qin Xie; Qiuling Shi; Yan Miao; Qingsong Yu; Hongfan Yu; Hong Yin; Xuefeng Leng; Yongtao Han; Hong Zhou
Journal:  Support Care Cancer       Date:  2021-11-24       Impact factor: 3.603

5.  Especially for neuro-oncologists-minimally important differences for the EORTC QLQ-C30 in glioma patients.

Authors:  Tito R Mendoza
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 13.029

Review 6.  Comprehensive Care for Patients with Sarcoidosis.

Authors:  Catharina C Moor; Vivienne Kahlmann; Daniel A Culver; Marlies S Wijsenbeek
Journal:  J Clin Med       Date:  2020-02-01       Impact factor: 4.241

7.  Web-Based Return of Individual Patient-Reported Outcome Results Among Patients With Lymphoma: Randomized Controlled Trial.

Authors:  Simone Oerlemans; Lindy Paulina Johanna Arts; Jacobien M Kieffer; Judith Prins; Mels Hoogendoorn; Marjolein van der Poel; Ad Koster; Chantal Lensen; Wendy Bernadina Catharina Stevens; Djamila Issa; Johannes F M Pruijt; Margriet Oosterveld; René van der Griend; Marten Nijziel; Lidwine Tick; Eduardus F M Posthuma; Lonneke V van de Poll-Franse
Journal:  J Med Internet Res       Date:  2021-12-14       Impact factor: 5.428

Review 8.  Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries.

Authors:  Nils Wilking; Anna Bucsics; Lidlija Kandolf Sekulovic; Gisela Kobelt; Andrea Laslop; Lydia Makaroff; Alexander Roediger; Christoph Zielinski
Journal:  ESMO Open       Date:  2019-11-13

9.  Strategies to improve patient-reported outcome completion rates in longitudinal studies.

Authors:  Lene Kongsgaard Nielsen; Madeleine King; Sören Möller; Mary Jarden; Christen Lykkegaard Andersen; Henrik Frederiksen; Henrik Gregersen; Anja Klostergaard; Morten Saaby Steffensen; Per Trøllund Pedersen; Maja Hinge; Mikael Frederiksen; Bo Amdi Jensen; Carsten Helleberg; Anne Kærsgaard Mylin; Niels Abildgaard
Journal:  Qual Life Res       Date:  2019-09-23       Impact factor: 4.147

Review 10.  Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative.

Authors:  Linda Dirven; Maartje E Vos; Tobias Walbert; Terri S Armstrong; David Arons; Martin J van den Bent; Jaishri Blakeley; Paul D Brown; Helen Bulbeck; Susan M Chang; Corneel Coens; Mark R Gilbert; Robin Grant; Rakesh Jalali; Danielle Leach; Heather Leeper; Tito Mendoza; Lakshmi Nayak; Kathy Oliver; Jaap C Reijneveld; Emilie Le Rhun; Larry Rubinstein; Michael Weller; Patrick Y Wen; Martin J B Taphoorn
Journal:  Neurooncol Pract       Date:  2021-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.